These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 183139)

  • 1. Immune destruction of virus-infected cells early in the infectious cycle.
    Shore SL; Cromeans TL; Romano TJ
    Nature; 1976 Aug; 262(5570):695-6. PubMed ID: 183139
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man.
    Reichman RC; Dolin R; Vincent MM; Fauci AS
    Proc Soc Exp Biol Med; 1977 Sep; 155(4):571-6. PubMed ID: 197538
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysis of virus-infected target cells by antibody-dependent cellular cytotoxicity. I. General requirements of the reaction and temporal relationship between lethal hits and cytolysis.
    Romano TJ; Shore SL
    Cell Immunol; 1977 Apr; 30(1):66-81. PubMed ID: 193647
    [No Abstract]   [Full Text] [Related]  

  • 4. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
    Melewicz FM; Shore SL; Ades EW; Phillips DJ
    J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.
    Moller-Larsen A; Heron I; Haahr S
    Infect Immun; 1977 Apr; 16(1):43-7. PubMed ID: 194838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus.
    Shore SL; Nahmias AJ; Starr SE; Wood PA; McFarlin DE
    Nature; 1974 Sep; 251(5473):350-2. PubMed ID: 4372535
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease.
    Russell AS; Essery G
    Cancer; 1977 Jul; 40(1):42-5. PubMed ID: 195708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearanc of cytotoxic cells within the bronchus after local infection with herpes simplex virus.
    Clancy R; Rawls WE; Jagannath S
    J Immunol; 1977 Sep; 119(3):1102-5. PubMed ID: 197165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological destruction of herpes simplex virus I infected cells.
    Rager-Zisman B; Bloom BR
    Nature; 1974 Oct; 251(5475):542-3. PubMed ID: 4371311
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity to herpes simplex virus in man.
    Russell AS
    Am J Clin Pathol; 1973 Dec; 60(6):826-30. PubMed ID: 4357123
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-dependent cell-mediated cytotoxicity to target cells infected with herpes simplex viruses.
    Shore SL; Melewicz FM; Milgrom H; Nahmias AJ
    Adv Exp Med Biol; 1976; 73 Pt B():217-27. PubMed ID: 187023
    [No Abstract]   [Full Text] [Related]  

  • 13. The mechanism of recurrent infection by Herpesvirus hominis.
    Bierman SM
    Arch Dermatol; 1976 Oct; 112(10):1459-61. PubMed ID: 183607
    [No Abstract]   [Full Text] [Related]  

  • 14. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
    Shore SL; Melewicz FM; Gordon DS
    J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice.
    Nagafuchi S; Oda H; Mori R; Taniguchi T
    J Gen Virol; 1979 Sep; 44(3):715-23. PubMed ID: 231089
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells.
    Russell AS; Kaiser JT
    J Allergy Clin Immunol; 1976 Nov; 58(5):539-45. PubMed ID: 185242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral response to herpes simplex virus type 1 in latent and active infection.
    Santiago J; Gomez B
    J Infect Dis; 1988 Apr; 157(4):817-9. PubMed ID: 2831287
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural killer cytotoxicity and antibody dependent cellular cytotoxicity in human herpes simplex virus infection.
    Hristescu S; Sahnazarov N; MuĊ£iu A; Olinescu A
    Arch Roum Pathol Exp Microbiol; 1987; 46(4):333-46. PubMed ID: 2845886
    [No Abstract]   [Full Text] [Related]  

  • 19. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity in vivo.
    Voss LM; David CS; Showalter SD; Paya CV; Leibson PJ
    Int Immunol; 1992 Mar; 4(3):417-20. PubMed ID: 1314641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus vaccines.
    Wise TG; Pavan PR; Ennis FA
    J Infect Dis; 1977 Nov; 136(5):706-11. PubMed ID: 199677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.